Skip to main content

Advertisement

Log in

Monitoring with serum SP-A, SP-D, and KL-6 in a patient with interstitial pneumonia complicated with ANCA-associated glomerulonephritis

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

A 69-year-old woman was admitted to hospital, complaining of fatigue and dry cough. Her renal function deteriorated rapidly, and the laboratory findings showed elevated myeloperoxidase-specific anti-neutrophil cytoplasmic antibody (ANCA). Renal biopsy examination revealed crescentic glomerulonephritis (pauci-immune type), and linear opacities and a honeycomb appearance in both lower lobes was evident on the chest computed tomography scan. The patient was diagnosed as having ANCA-associated glomerulonephritis complicated with mild interstitial pneumonia (IP). Treatment with methylprednisolone pulse therapy improved both her renal function and IP, but her lung lesions worsened during the course of tapering the prednisolone doses. After careful observation, her IP improved gradually without specific treatment. Worsening or improvement of her lung lesions was accompanied by changes in the serological markers of IP, namely, surfactant protein-A, surfactant protein-D, and KL-6. We found that monitoring these markers was helpful in diagnosing and managing IP in our patient with ANCA-associated vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Bosch X, Mirapeix E, Font J, Cervera R, Ingelmo M, Khamashta MA, et al. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. Am J Kidney Dis. 1992;20:231–9.

    CAS  PubMed  Google Scholar 

  2. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol. 1998;275(1 Pt 1):L1–13.

    CAS  PubMed  Google Scholar 

  3. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162:1109–14.

    Article  CAS  PubMed  Google Scholar 

  4. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung disease. Am J Respir Crit Care Med. 2002;165:378–81.

    Article  PubMed  Google Scholar 

  5. Yamada H. ANCA: associated lung fibrosis. Semin Respir Crit Med. 2011;32:322–7.

    Article  Google Scholar 

  6. Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K, et al. ANCA-associated systemic vasculitis in Japan: clinical features and prognosis. Clin Exp Nephrol. 2012;16:580–8. doi:10.1007/s1015701205982.

    Article  CAS  PubMed  Google Scholar 

  7. Muller Kobold AC, van der Geld YM, Limburg PC, Tervaert JW, Kallenberg CG. Pathophysiology of ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 1999;14:1366–75.

    Article  CAS  PubMed  Google Scholar 

  8. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J. 2010;36:116–21.

    Article  CAS  PubMed  Google Scholar 

  10. Foucher P, Heeringa P, Peterson AH, Huitema MG, Brouwer E, Tervaert JW, et al. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med. 1999;160:987–94.

    Article  CAS  PubMed  Google Scholar 

  11. Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med. 2000;162:258–63.

    Article  CAS  PubMed  Google Scholar 

  12. Iwata Y, Wada T, Furuichi K, Kitagawa K, Kokubo S, Kobayashi M, et al. Serum levels of KL-6 reflect disease activity of interstitial pneumonia associated with ANCA-related vasculitis. Intern Med. 2001;40:1093–7.

    Article  CAS  PubMed  Google Scholar 

  13. Fujita S, Hirayama K, Ogawa Y, Shimohata H, Kobayashi M. Mizoribine reduces serum KL-6 levels in ANCA-associated vasculitis. Clin Exp Nephrol. 2010;14:203–4.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fumihiko Takahashi.

About this article

Cite this article

Takahashi, F., Miura, E., Shibukawa, K. et al. Monitoring with serum SP-A, SP-D, and KL-6 in a patient with interstitial pneumonia complicated with ANCA-associated glomerulonephritis. CEN Case Rep 3, 5–9 (2014). https://doi.org/10.1007/s13730-013-0074-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-013-0074-1

Keywords

Navigation